NCT04413370

Brief Summary

Dry eye is one of the most common ocular surface diseases. Its pathogenic factors are related to multiple etiology. Because of the complexity of the pathogenesis of dry eye, the diversity of related examinations, and the inconsistency of symptoms and signs of dry eye patients, the diagnosis of dry eye has higher requirements on the professional technology and examination equipment of ophthalmologists. The purpose of this study is to establish a case-control cohort of dry eye patients. Multimodal data will be collected from participants, including medical history information, ocular surface disease index scale (OSDI), anterior segment photography, and treatment outcome of dry eye patients. The correlation between the characteristics of anterior segment images and dry eye diagnosis will be explored by artificial intelligence algorithms. The purpose of this study was to develop an artificial intelligence dry eye screening and referral system.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
518

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

April 25, 2022

Status Verified

April 1, 2022

Enrollment Period

2.3 years

First QC Date

May 28, 2020

Last Update Submit

April 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area under the curve (severe)

    AUC values for predicting whether subject need to be referral or not.

    up to 1 month

Secondary Outcomes (2)

  • Area under the curve (each group)

    up to 1 month

  • Accuracy, true positive rate, and true negative rate

    up to 1 month

Study Arms (3)

Severe Group

This group of subjects needed a referral to the hospital for further treatments.

Diagnostic Test: Dry eye diagnostic test

Mild group

This group of subjects was diagnosed with dry eye but can use artificial tears instead of further treatment.

Diagnostic Test: Dry eye diagnostic test

Follow-up group

This group of subjects had no dry eye symptoms and signs and belonged to the normal control group.

Diagnostic Test: Dry eye diagnostic test

Interventions

The artificial intelligent dry eye screening platform

Follow-up groupMild groupSevere Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects who are equal or over 18 years old with or without dry eye symptoms and signs.

You may qualify if:

  • Subjects whose age are greater than or equal to 18 years old;
  • Subjects who can cooperate with the inspection;
  • Subjects who agree to participate in the study and sign the consent form.

You may not qualify if:

  • Subjects who cannot do the inspection.
  • Subjects who suffer from diseases that compromise the inspection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510632, China

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 2, 2020

Study Start

January 6, 2020

Primary Completion

April 19, 2022

Study Completion

August 1, 2022

Last Updated

April 25, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations